ZA991245B - Hapten-modified tumor cell membranes, and methods of making and using hapten-modified tumor cell membranes. - Google Patents

Hapten-modified tumor cell membranes, and methods of making and using hapten-modified tumor cell membranes.

Info

Publication number
ZA991245B
ZA991245B ZA9901245A ZA991245A ZA991245B ZA 991245 B ZA991245 B ZA 991245B ZA 9901245 A ZA9901245 A ZA 9901245A ZA 991245 A ZA991245 A ZA 991245A ZA 991245 B ZA991245 B ZA 991245B
Authority
ZA
South Africa
Prior art keywords
hapten
tumor cell
cell membranes
modified tumor
making
Prior art date
Application number
ZA9901245A
Inventor
David Berd
Takami Sato
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jefferson filed Critical Univ Jefferson
Publication of ZA991245B publication Critical patent/ZA991245B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • A61K39/001102Receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012Haptens, e.g. di- or trinitrophenyl (DNP, TNP)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9901245A 1998-02-17 1999-02-17 Hapten-modified tumor cell membranes, and methods of making and using hapten-modified tumor cell membranes. ZA991245B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2501298A 1998-02-17 1998-02-17

Publications (1)

Publication Number Publication Date
ZA991245B true ZA991245B (en) 1999-08-18

Family

ID=21823570

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901245A ZA991245B (en) 1998-02-17 1999-02-17 Hapten-modified tumor cell membranes, and methods of making and using hapten-modified tumor cell membranes.

Country Status (12)

Country Link
EP (1) EP1054690A2 (en)
JP (1) JP2002502880A (en)
KR (1) KR20010041018A (en)
CN (1) CN1291105A (en)
AR (1) AR015237A1 (en)
AU (1) AU2686999A (en)
BR (1) BR9907912A (en)
CA (1) CA2320969A1 (en)
IL (1) IL137791A0 (en)
PL (1) PL342856A1 (en)
WO (1) WO1999040925A2 (en)
ZA (1) ZA991245B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366240A1 (en) * 1998-04-09 2005-01-24 Thomas Jefferson University A method of inducing an anti-tumor response against a lung metastasis in a melanoma patient
US6248585B1 (en) 1998-11-19 2001-06-19 Thomas Jefferson University Compositions for preserving haptenized tumor cells for use in vaccines
JP2004507446A (en) * 2000-02-04 2004-03-11 トーマス・ジェファーソン・ユニバーシティ Immunotherapy of low-dose haptenized tumor cells and tumor cell extracts
US7297330B2 (en) 2000-02-04 2007-11-20 Thomas Jefferson University Low dose haptenized tumor cell and tumor cell extract immunotherapy
US7612251B2 (en) 2000-09-26 2009-11-03 Pioneer Hi-Bred International, Inc. Nucleotide sequences mediating male fertility and method of using same
EP1551225A4 (en) * 2002-06-10 2011-05-25 Avax Technologies Inc Cryopreservation of haptenized tumor cells
US11214603B2 (en) 2016-04-27 2022-01-04 The Regents Of The University Of Michigan C3D cellular and acellular vaccines for the prevention and treatment of cancer
CN115137814A (en) * 2022-07-01 2022-10-04 可蓝赛生物医药(上海)有限公司 Tumor vaccine adjuvant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086134A (en) * 1973-09-18 1978-04-25 University Of Glasgow Method for preparation of vaccine against feline leukemia
BR9609026A (en) * 1995-06-07 1999-07-06 Univ Jefferson Process composition for the treatment of cancer and detection for the production of cytokine by tumors to determine the efficacy of an autologous and diagnostic kit for detection for efficacy of autologous cellular compounds

Also Published As

Publication number Publication date
CN1291105A (en) 2001-04-11
PL342856A1 (en) 2001-07-16
JP2002502880A (en) 2002-01-29
AU2686999A (en) 1999-08-30
CA2320969A1 (en) 1999-08-19
IL137791A0 (en) 2001-10-31
AR015237A1 (en) 2001-04-18
BR9907912A (en) 2000-10-24
WO1999040925A2 (en) 1999-08-19
EP1054690A2 (en) 2000-11-29
KR20010041018A (en) 2001-05-15
WO1999040925A3 (en) 1999-10-21

Similar Documents

Publication Publication Date Title
ZA200003392B (en) Cutting elements and methods of manufacture thereof.
ZA993722B (en) Ceramic membrane reformer.
GB2330836B (en) Solid polyelectrolyte membrane for fuel cells,and method for producing it
HK1043876A1 (en) Solid gel membrane
AU2002213273A1 (en) Stenoprophiluric matrices, and methods of making and using the same
HK1053996A1 (en) Catalyst, method of making, and reactions using the catalyst
ZA991307B (en) Antibodies against human CD40.
ZA99452B (en) Antibodies against human IL-12.
AU6422599A (en) Methods for prolonging cell membrane permeability
MXPA99001199A (en) Enhancing gel strength.
EP1062027A4 (en) Microporous membrane and method for providing the same
ZA978256B (en) Electrolyte.
MXPA01012104A (en) Rhodium electrocatalyst and method of preparation.
WO2000018914A3 (en) Novel dkr polypeptides
TR199900113A3 (en) Flexible cell material, method for its assembly and preparation.
ZA991061B (en) Tea manufacture.
ZA200107849B (en) Water treatment system and method using permeable embankments, weirs, walls, or the like.
SG116429A1 (en) Cell control method and cell system.
IL156050A0 (en) Porous polymeric biomaterials, preparation method and uses
ZA971182B (en) Electrochemical cell.
AU4224599A (en) Anti-prostate cancer vaccines, and methods of making, using and evaluating the same
MXPA01011816A (en) Battery grid and method of making.
AU3244100A (en) Chromatography devices, porous medium modules used in chromatography devices, and methods for making porous medium modules
EP1113609A4 (en) Broadcasting apparatus and method, receiving apparatus and method, and medium
ZA991245B (en) Hapten-modified tumor cell membranes, and methods of making and using hapten-modified tumor cell membranes.